![Dame Molly Stevens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dame Molly Stevens
Directeur/Membre du Conseil chez
The National Gallery
Profil
Dame Molly Morag Stevens is the founder of SPARTA Biodiscovery Ltd., founded in 2022.
Dr. Stevens was the founder of RepRegen Ltd., founded in 2006, and held the titles of Director & Chief Scientific Officer from 2006 to 2013.
Current jobs include Professor at Imperial College London, Trustee at The National Gallery since 2018, Advisor at Impact Investment Partners LLP, and Venture Partner at Catalio Capital Management LP.
Education history includes an undergraduate degree from the University of Bath in 1995 and a doctorate from Nottingham Trent University in 2000.
Postes actifs de Dame Molly Stevens
| Sociétés | Poste | Début |
|---|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The National Gallery
 The National Gallery Other Consumer ServicesConsumer Services Operates museums and art galleries | Directeur/Membre du Conseil | 02/07/2018 |
Impact Investment Partners LLP
 Impact Investment Partners LLP Investment ManagersFinance Impact Investment Partners invests in companies located in the United Kingdom. The firm targets companies operating on a broad range of sectors. It provides financing for growth stage capital requirements. | Consultant / Advisor | - |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Private Equity Investor | - |
Anciens postes connus de Dame Molly Stevens
| Sociétés | Poste | Fin |
|---|---|---|
RepRegen Ltd.
 RepRegen Ltd. Medical/Nursing ServicesHealth Services Develops synthetic, biologically-active and tissue engineering products | Fondateur | 07/03/2013 |
Sparta Biodiscovery Ltd.
 Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Fondateur | - |
Formation de Dame Molly Stevens
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nottingham Trent University
 Nottingham Trent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Gallery
The National Gallery Other Consumer ServicesConsumer Services Operates museums and art galleries | Consumer Services |
RepRegen Ltd.
RepRegen Ltd. Medical/Nursing ServicesHealth Services Develops synthetic, biologically-active and tissue engineering products | Health Services |
Impact Investment Partners LLP
Impact Investment Partners LLP Investment ManagersFinance Impact Investment Partners invests in companies located in the United Kingdom. The firm targets companies operating on a broad range of sectors. It provides financing for growth stage capital requirements. | Finance |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Finance |
Sparta Biodiscovery Ltd.
Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Health Technology |
